Compound Radar

Edwards Lifesciences Corporation (EW) Stock Analysis

United States · Healthcare / Medical Devices

Price $86.72
Market cap $49.99B
Next earnings Oct 29, 2026
Entry status Watch $81.40–$86.44

Last updated Sep 8, 2026

Health Check

Last analyzed Sep 7, 2026

80
80/100 Elite Quality
  • Financial Health 85
  • Profitability 60
  • Business Quality 100
  • Balance Sheet 65
  • Cash Flow 80

Why this rating?

Health 80/100 — Elite Quality

Strongest Business Quality 100/100
Softest Profitability 60/100
Watch

Worth tracking, but timing is mixed — not a clear setup yet.

Company overview

Edwards Lifesciences Corporation (EW) is a Medical Devices company in the Healthcare sector. Compound Radar rates Edwards Lifesciences Corporation 80/100 (Elite Quality) due to high business quality, steady revenue growth, and manageable leverage.

Investment profile

  • Quality High
  • Growth Moderate
  • Balance Sheet Adequate
  • Valuation Fair

Financial highlights

Valuation

  • P/E 51.62
  • Forward P/E 25.68
  • PEG 1.92
  • EV/Revenue 7.43

Profitability

  • Revenue Growth 13.6%
  • Gross Margin 77.8%
  • Operating Margin 29.8%
  • Net Margin 15.4%
  • ROE 9.2%

Financial strength

  • Cash $4.25B
  • Debt $704.40M
  • Net Cash $3.55B
  • Free Cash Flow $1.33B
  • Current Ratio 4.52

Similar companies

Peers in Medical Devices, ranked by Financial Health.

Company Ticker
Price Current price

Latest quoted price for the name. Helps anchor the setup in today’s market level.

Health Entry

View all in Medical Devices →

FAQ

How Compound Radar scores and tracks Edwards Lifesciences Corporation (EW).

View Methodology & FAQ →